Year-over-year earnings per share growth for the last twelve months: MDxHealth SA (MDXH)

Corporate emblem and logo of mdxhealth.com (MDXH)

The resilience of MDxHealth SA (MDXH) is based on the implementation of proprietary prostate cancer diagnostics and the expansion of insurance coverage. The current quarterly EPS pace confirms this trajectory, with the value recorded at -51.00. Cash flow stability relies on the narrow niche of onco-urology, while process efficiency is enhanced through the deployment of robotic systems for DNA isolation and report automation.

mdxhealth.com (MDXH) Year-over-year net earnings per share growth for the last 12 months: for the period 07/04/2022 - 11/13/2026

Comprehensive metric breakdowns and analytics for MDxHealth, Inc. (MDXH)

- share price and expert price forecast:
Stock Price MDxHealth|MDXH - Analyst Median Target
- company stock exchange capitalization indicators:
Market Value MDxHealth Inc.|MDXH - Company Buyout Price
- book capitalization data:
Net Assets per Single Share MDxHealth SA|MDXH - Company Net Assets|Market Capitalization to Book Value Ratio mdxhealth.com|MDXH - Total Business Assets
- debt level and financial liquidity data:
Total Debt to Equity Ratio MDxHealth SA|MDXH - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital MDxHealth SA|MDXH - Aggregate Debt Obligations|Debts to Book Capitalization MDxHealth Inc.|MDXH - Long-Term Debt|Company Short-Term Debts MDxHealth SA|Quick Liquidity mdxhealth.com
- earnings and market multiples details:
MDXH - Company Net Income|Future Profit MDxHealth SA|MDXH - Market Price to Net Income Ratio|Forward P/E Multiple MDxHealth Inc.|MDXH - Growth-Adjusted Payback Ratio|Enterprise Value to EBITDA Ratio MDxHealth Inc.|MDXH - Income before deduction of interest, taxes and amortization|Earnings per share for the last twelve months MDxHealth SA|MDXH - Net earnings per share for the last four quarters|Quarterly EPS earnings growth mdxhealth.com|MDXH - Earnings growth in current year|Net earnings per share growth forecast for next year MDxHealth SA
Summary company analytics:MDxHealth - MDXH
Finished products of MDxHealth, Inc.

This metric measures the quarterly dynamics of net income per share for MDxHealth SA (MDXH), reflecting the efficiency of capital generation. Growth in this value confirms the monetization of DNA isolation patents and the recognition of tests within medical protocols. By analyzing the current level of quarterly EPS growth, an investor assesses the impact of insurance reimbursements on profitability. The metric provides a real-time assessment of the business's actual productivity. A rational approach prevents overpaying for the asset.

Analysis of competing companies

A: Quarterly EPS earnings growth|DGX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Illumina Corp|Exact Sciences Inc. (EXAS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Revvity, Inc. (RVTY)|Year-over-year net earnings per share growth for the last 12 months bio-rad.com BIO|Quarterly EPS earnings growth NNNN (Anbio)|SHC: Year-over-year earnings per share growth for the last 12 months|QDEL: Year-over-year net earnings per share growth for the last 12 months|OPK (OPKO Health Corp.) - Year-over-year earnings per share growth for the last 12 months|CDNA: Quarterly EPS earnings growth|maravai.com - Year-over-year earnings per one share growth for the last 12 months|FLGT (Fulgent Genetics) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Standard BioTools Inc LAB|Quarterly EPS earnings growth CTKB|Quarterly EPS earnings growth OraSure Corp (OSUR)|Year-over-year earnings per share growth for the last twelve months Exagen XGN|luciddx.com - Year-over-year earnings per share growth for the last twelve months|PRE: Year-over-year net earnings per share growth for the last 12 months|Insight Molecular Diagnostics - Year-over-year earnings per share growth rate for the last twelve months|TRIB: Quarterly EPS earnings growth|ProPhase Labs Corp - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months AIMD|CODX: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months HeartSciences (HSCS)|Year-over-year net earnings per share change for the last twelve months Biomerica Inc.|Quarterly EPS earnings growth CDIO (Cardio Diagnostics Holdings)|Quarterly EPS earnings growth Onconetix Corporation ONCO|VRAX - Year-over-year earnings per share growth for the last twelve months|bluejaydx.com (BJDX) - Year-over-year net earnings per share growth for the last 12 months|AWH: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months AXDX|Year-over-year net earnings per share growth for the last 12 months CNTG|Year-over-year earnings per share growth for the last 12 months ENZ (Enzo)|Quarterly EPS earnings growth FRES|GENE (gtglabs.com) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months 23andMe ME|PMD - Year-over-year net earnings per share growth for the last 12 months